These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21310633)

  • 1. Commercial mouthwashes are more effective than azole antifungals against Candida albicans biofilms in vitro.
    Ramage G; Jose A; Coco B; Rajendran R; Rautemaa R; Murray C; Lappin DF; Bagg J
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Apr; 111(4):456-60. PubMed ID: 21310633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth.
    Cateau E; Rodier MH; Imbert C
    J Antimicrob Chemother; 2008 Jul; 62(1):153-5. PubMed ID: 18407917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Activity of Miltefosine against Candida albicans under Planktonic and Biofilm Growth Conditions and In Vivo Efficacy in a Murine Model of Oral Candidiasis.
    Vila TV; Chaturvedi AK; Rozental S; Lopez-Ribot JL
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7611-20. PubMed ID: 26416861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
    Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
    Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of Candida biofilms to histatin 5 and fluconazole.
    Konopka K; Dorocka-Bobkowska B; Gebremedhin S; Düzgüneş N
    Antonie Van Leeuwenhoek; 2010 May; 97(4):413-7. PubMed ID: 20140514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal susceptibility of Candida albicans in biofilms.
    Tobudic S; Kratzer C; Lassnigg A; Presterl E
    Mycoses; 2012 May; 55(3):199-204. PubMed ID: 21793943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic activity of lysozyme and antifungal agents against Candida albicans biofilms on denture acrylic surfaces.
    Samaranayake YH; Cheung BP; Parahitiyawa N; Seneviratne CJ; Yau JY; Yeung KW; Samaranayake LP
    Arch Oral Biol; 2009 Feb; 54(2):115-26. PubMed ID: 19038377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymol inhibits Candida albicans biofilm formation and mature biofilm.
    Braga PC; Culici M; Alfieri M; Dal Sasso M
    Int J Antimicrob Agents; 2008 May; 31(5):472-7. PubMed ID: 18329858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible role of azole and echinocandin lock solutions in the control of Candida biofilms associated with silicone.
    Cateau E; Berjeaud JM; Imbert C
    Int J Antimicrob Agents; 2011 Apr; 37(4):380-4. PubMed ID: 21353488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of two different methods for the investigation of in vitro susceptibilities of planktonic and biofilm forming Candida species to antifungal agents].
    Kaynak Onurdağ F; Ozgen S; Abbasoğlu U; Gürcan IS
    Mikrobiyol Bul; 2010 Oct; 44(4):619-31. PubMed ID: 21063974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-Resistance of clinical isolates of Candida albicans and Candida glabrata to over-the-counter azoles used in the treatment of vaginitis.
    Cross EW; Park S; Perlin DS
    Microb Drug Resist; 2000; 6(2):155-61. PubMed ID: 10990271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azole derivatives with naphthalene showing potent antifungal effects against planktonic and biofilm forms of Candida spp.: an in vitro and in silico study.
    Sari S; Koçak E; Kart D; Özdemir Z; Acar MF; Sayoğlu B; Karakurt A; Dalkara S
    Int Microbiol; 2021 Jan; 24(1):93-102. PubMed ID: 32889579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of amphotericin B, anidulafungin, caspofungin, micafungin, posaconazole, and voriconazole against Candida albicans with decreased susceptibility to fluconazole from APECED patients on long-term azole treatment of chronic mucocutaneous candidiasis.
    Rautemaa R; Richardson M; Pfaller MA; Perheentupa J; Saxén H
    Diagn Microbiol Infect Dis; 2008 Oct; 62(2):182-5. PubMed ID: 18597968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Techniques for antifungal susceptibility testing of Candida albicans biofilms.
    Ramage G; López-Ribot JL
    Methods Mol Med; 2005; 118():71-9. PubMed ID: 15888936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular phospholipase production of oral Candida albicans isolates from smokers, diabetics, asthmatics, denture wearers and healthy individuals following brief exposure to polyene, echinocandin and azole antimycotics.
    Ellepola AN; Samaranayake LP; Khan ZU
    Braz J Microbiol; 2016; 47(4):911-916. PubMed ID: 27522928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms.
    Katragkou A; Chatzimoschou A; Simitsopoulou M; Dalakiouridou M; Diza-Mataftsi E; Tsantali C; Roilides E
    Antimicrob Agents Chemother; 2008 Jan; 52(1):357-60. PubMed ID: 17938192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro effectiveness of anidulafungin against Candida sp. biofilms.
    Rosato A; Piarulli M; Schiavone BP; Catalano A; Carocci A; Carrieri A; Carone A; Caggiano G; Franchini C; Corbo F; Montagna MT
    J Antibiot (Tokyo); 2013 Dec; 66(12):701-4. PubMed ID: 24022607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic anticandidal activity of pure polyphenol curcumin I in combination with azoles and polyenes generates reactive oxygen species leading to apoptosis.
    Sharma M; Manoharlal R; Negi AS; Prasad R
    FEMS Yeast Res; 2010 Aug; 10(5):570-8. PubMed ID: 20528949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactive oxygen species-inducing antifungal agents and their activity against fungal biofilms.
    Delattin N; Cammue BP; Thevissen K
    Future Med Chem; 2014 Jan; 6(1):77-90. PubMed ID: 24358949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinatorial drug approaches to tackle Candida albicans biofilms.
    De Cremer K; Staes I; Delattin N; Cammue BP; Thevissen K; De Brucker K
    Expert Rev Anti Infect Ther; 2015 Aug; 13(8):973-84. PubMed ID: 26070384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.